About PRIME
Advertise With Us
Contact Us

Home
Digital Issue
Categories
Features
News
Sign Up
Login

Select Page

Enjoy your July/August 2019 issue of PRIME

VOL. 9 ISSUE 4

Share:

PreviousCutera Redefines the Muscle Sculpting Market with US Commercial Launch of truSculpt® flex

NextSkincare in practice

Related Posts

CoolSculpting® – The #1 most requested non-surgical body-sculpting procedure, expands Its body contouring options

CoolSculpting® – The #1 most requested non-surgical body-sculpting procedure, expands Its body contouring options

November 20, 2017

Positive results from second pivotal phase 3 study of brodalumab in patients with moderate-to-severe plaque psoriasis announced

Positive results from second pivotal phase 3 study of brodalumab in patients with moderate-to-severe plaque psoriasis announced

November 19, 2014

Janssen announces U.S. FDA approval Of STELARA® (ustekinumab) for the treatment of adolescents with moderate to severe plaque psoriasis

Janssen announces U.S. FDA approval Of STELARA® (ustekinumab) for the treatment of adolescents with moderate to severe plaque psoriasis

October 20, 2017

FDA Grants ReCell® Expedited Access Pathway Designation

FDA Grants ReCell® Expedited Access Pathway Designation

December 14, 2015

Search

Search for:

Login Status

Username or Email

Password

Forgot? Register

January/February 2026 Issue

Advertisement

Upcoming Events

No events are found.

Categories

Injectables
Dermatology
Anti-ageing
Body Contouring
Invasive treatments
Case Study
Practice Management
Sponsored
Industry Insider
Company Profile
PRIME People
Meeting reviews
Commentary

Designed by Elegant Themes | Powered by WordPress

Contact Us
Editorial Board
Terms & Conditions
Privacy Policy